Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZOC2017217 in Subjects With Age-Related Cataract
NCT07395986Phase 2Active, not recruiting
- Sponsor
- Ocusun
- Start
- Feb 2026
- Primary completion
- Feb 2027
- Modality
- Modified Peptides, Antibody-Drug Conjugates (ADCs), Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of ZOC2017217 in age-related cataract, sponsored by Ocusun. Started Feb 2026; status: active, not recruiting.
02
Drugs
ZOC2017217
03
Conditions
age-related cataract
Beyond the preview
Go deeper on NCT07395986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07395986.